Orbit
Resources:
For survivors:
COG Survivorship Guidelines: Keeping your eyes healthy after treatment for childhood cancer
COG Survivorship Guidelines: Cataracts after treatment for childhood cancer
For HCPs:
Late Effects of Childhood Cancer - by Hamish Wallace and Daniel Green
Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach by Cindy L. Schwartz, Wendy L. Hobbie, Louis S. Constine, and Kathleen S. Ruccione
Late Effects of the Special Senses at the National Cancer Institute
References:
1) Whelan KF, Stratton K, Kawashima, et al. Ocular late effects in Childhood and Adolescent Cancer Survivors: A Report From Childhood Cancer Survivor Study. Pediatr Blood Cancer 2010:54:103-109
2) Lackner H, Benesch M, Schagerl S et al. Prospective evaluation of late effects of childhood cancer therapy with a followup over 9 years. Eur J Pediatr 2000: 159:750-758
3) Wallace WHB and Green DM. (2004) Late effects of childhood cancer. (pp 49-53) London, England: Arnold.
4) Schwartz CL, Hobbie WL, Constine LS, et al. (2005) Survivors of Childhood and Adolescent Cancer. (pp 95-123) . Heidelberg, Germany: Springer.
5) Franklin RM, Kenyon KR, Tutschka PJ et al. Ocular manifestations of graft vs host disease. Opthalmology 1983:90:4-13
6) Baird K, Cooke K and Schultz KR. Chronic Graft Versus Host Disease (GVHD) in Children. Pediatr Clin N Am. 2010:57:297-322
7) Finger PT. Radiation Therapy for Orbital Tumors: Concepts, Current Use and Ophthalmic Radiation Side Effects. Surv Ophthalmol 2009:54:545-568
8) Finger PT. Radiation Therapy for choroidal melanoma. Surv Ophthalmol 1997:42(3):215-232
9) Sagerman R, Alberti WF. Radiosensitivity of ocular and orbital structures. In Sagerman RH, Alberti WE (eds): Radiotherapy of Intraocular and Orbital Tumors. Berlin. Springer. 2003 pp269-280
10) Claus F, Boterberg T, Ost P, De Neve W. Short term toxicity profile for 32 sinonasal cancer patients treated with IMRT. Can we avoid dry eye syndrome ? Radiother Oncol 2002:64(2):205-208
11) Kennerdell JS, Flores NE, Hartsock RJ. Low dose radiotherapy for lymphoid lesions of the orbit and ocular adnexa. Ophthal Plast Reconstr Surg 1999:15(2):129-133
12) Phillips C, Sexton M, Wheeler G, Mckenzie J. Retinoblastoma: review of 30 years experience with external beam radiotherapy. Australas Radiol. 2003:47(3):226-230
13) Finger PT. Plaque radiation therapy for malignant melanoma of the iris and ciliary body. Am J Ophthalmol. 2001:132(3):328-335
14) Ti SE, Tan DT. Tectonic corneal lamellar grafting for severe scleral melting after pterygium surgery. Ophthalmology 2003:110(6):1126-1136
15) Radcliffe N, Finger P. Eye cancer related glaucoma: current concepts. Surv Ophthalmo. 2009:54(1):47-73
16) Finger PT. Radiation retinopathy is treatable with antivascular endothelial growth factor bevacizumab (Avastin). Int J Radiat Oncol Biol Phys. 2008:70(4):974-977
17) Parsons JT, Bova FJ, Fitzgerald CR et al. Radiation retinopathy after external beam irradiation: analysis of time dose factors. Int J Radiat Oncol Biol Phys 1994:30(4):765-773
18) Jiang GL, Tucker SL, Guttenberger R et al. Radiation induced injury to the visual pathway. Radiother Oncol 1994:30(1):17-25
19) Finger PT, Kurli M. Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol. 2005:89(6):730-738
20) Thorne JE, Maguire AM. Good visual outcome following laser therapy for proliferative radiation retinopathy. Arch Ophthalmology. 1999:117(1):125-126
21) Al-Tweigeri T, Nabholtz JM, Mackey JR. Ocular toxicity and cancer chemotherapy. A review. Cancer 1996:78:1359-1373
22) Sidi Y, Douer D, Pinkhas J. Sicca syndrome in a patient with toxic reaction to busulfan. JAMA 1977:238:1951
23) Straus DJ, Mausolf FA, Ellerby RA. Cicatricial ectropian secondary to 5 fluorouracil therapy. Med Pediatr Oncol 1977:3:15-19
24) Esmaeli B, Valero V, Ahmadi A et al. Canalicular stenosis secondary to docetaxel (taxotere). A newly recognized side effect. Ophthalmology 2001:108:994-995
25) Miller D Pecxon JD. Corticosteroid and functions in the anterior segment of the eye. Am J Ophthalmol 1965:59:31
26) Palmer ML, Hyndiuk RA. Toxicology of corticosteroids and other antiinflammatory agents. In: Albert DM, Jakobiec FA (eds) Principals and practice of ophthalmology, 2nd edn. Saunders, Philadelphia, PA, 2000. pp399-416.
27) Albert DM, Wong VG, Henderson ES. Ocular complications of vincristine therapy. Arch Ophthalmol 1967:78:709-713
28) Podos SM, Canellos GP. Lens changes in chronic granulocytic leukemia. Possible relationship to chemotherapy. Am J Ophthalmol 1969:68:500-504\
29) Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. II. The effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol. 1963:70:492-499
30) Shingleton BJ, Bienfang DC, Albert DM et al. Ocular toxicity associated with high dose carmustine. Arch Ophthalmol 1982:100:1766-1772
31) Miller DF, Bay JW, Lederman RJ. Ocular and orbital toxicity following intra-carotid injection of BCNU and cisplatin for malignant gliomas. Ophthalmology 1985:92:402-406
32) Margo CE, Murtagh FR. Ocular and orbital toxicity after intra-carotid cisplatin therapy. Am J Ophthalmol 1993:116:508-509
33) Millay RH, Klein ML, Shults WT. Maculopathy associated with combination chemotherapy and osmotic opening of the blood brain barrier. Am J Ophthalmol 1986:102:626-632
34) Lauer AK, Wobig JL, Shults WT et al. Severe ocular and orbital toxicity after intracartotid etoposide phosphate and carboplatin therapy. Am J Ophthalmol. 1999:127:230-233
35) Van Dalen JT, Sherman MD. Corticosteroid-induced exopthalmos. Doc Opthalmol. 1989:72:273-277
36) Bixenman WW, Nicholls JV, Warwick OH. Oculomotor disturbances associated with 5-fluorouracil chemotherapy. Am J Ophthamol 1968:83:604-608
37) Halperin EC, Perez CA, Brady LW. (2007) Perez and Brady's Principles and Practice of Radiation Oncology. (pp 328) Lippincott Williams & Wilkins
38) Fajardo LF et al. (2001) Radiation Pathology. Oxford University Press, USA.
39) Gunderson LL and Tepper JE. (2007) Clinical Radiation Oncology. (pp624-625) Elsevier. Philadelpia, PA, USA
